U.S., Europe oppose Israeli bill on intellectual property rights

09/13/2004 | Jerusalem Post (free registration), The

The U.S. and several European countries object to an intellectual property rights bill likely to be approved by the Israeli government. The measure would only provide marketing exclusivity for pharmaceutical firms, but not protect confidentiality of proprietary tests and clinical data used to register a drug, thus allowing Israeli generic firms to produce drug copies. The issue prompted representatives of Germany, France, Denmark and Switzerland to express concern over Israel's unwillingness to honor European trade agreements.

View Full Article in:

Jerusalem Post (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA